It's a minor mystery in the drug world that's become a topic of debate among AstraZeneca (AZN)'s Symbicort sales staff: Why, in TV commercials for the asthma drug, is the presenter represented as a ...

AstraZeneca’s Don Apruzzese, formerly senior director of consumer marketing, is moving over to become regional commercial leader on the Symbicort for asthma launch, scheduled for mid-2007. In a world ...

LargePharma_SymbicortAstraZeneca’s Symbicort, the second-to-market ICS/LABA combo behind GlaxoSmithKline’s Advair, faced an uphill battle on its launch in June 2007, squaring off against a firmly ...

AstraZeneca’s aging respiratory giant Symbicort won a coveted pediatric exclusivity nod from the FDA on Wednesday, giving the brand a longer life—and potentially hundreds of millions in additional ...

AstraZeneca Announces Symbicort Is Now Available In The U.S. U.S. Asthma Sufferers Now Have a New Choice of Combination Therapy to Help Achieve Asthma Control LONDON ...

Iconovo, which develops complete inhalation products for a global market, is expanding its collaboration with Amneal for Symbicort in the ICOres inhaler to include additional territories with a ...

The SMART (Symbicort Maintenance and Reliever Therapy) approach allows patients to increase the dose of Symbicort (a combination of an inhaled corticosteroid and long-acting bronchodilator) during ...

Shares in Anglo-Swedish drugmaker AstraZeneca were in the ascendancy this morning after it revealed that its combination drug for asthma, Symbicort, had been approved in the USA. Shares in ...